... positron emission tomography (PET) imaging regularly in biochemically recurrent PCa. Overall, 61% of participants considered PSMA-radioligand therapy to be very useful or extremely useful. PSMA PET imaging in high-risk PCa is more often considered by urologists working in a university setting than...

... time, and PSA velocity in patients with biochemical recurrence (BCR) of PCa after curative-intent treatment. Methods: Data from 59 patients who underwent 18 F-fluciclovine PET/CT for BCR after radical prostatectomy or radiotherapy were retrieved from a single institution database. Patients already...

...YiRui Guo; Yu Tian; Yuxin Deng; ChunMei Lu; YanJuan Wang; Chunjing Yu Purpose: The aim of this study was to explore the diagnostic value of different fluorine-18 ( 18 F)-labeled tracers for lymph node/bone metastasis and biochemical recurrence detection in advanced prostate cancer (PCa). Methods...

... group, n = 534; bGS 3 + 4 group, n = 81). Results: The adverse pathological features were significantly higher in the bGS 3 + 4 group (16.7 vs. 49.4%, p < 0.001). Biochemical recurrence (BCR)-free survival was also significantly lower in this group ( p < 0.001). In a multivariate analysis...

...Walter Artibani; Antonio Benito Porcaro; Vincenzo De Marco; Maria A. Cerruto; Salvatore Siracusano How to manage patients with prostate cancer (PCa) with biochemical recurrence (BCR) following primary curative treatment is a controversial issue. Importantly, this prostate-specific antigen (PSA...

... cancer (PCa) predicts biochemical recurrence (BCR) after radical prostatectomy (RP). Material and Methods: Genome-wide methylation analysis was performed using the GoldenGate Methylation Cancer Panel-I (Illumina, Inc.) on 10 normal prostate tissues and 58 tumor samples from patients treated by RP...

..., defined by either biochemical recurrence or necessity of any additional therapy (Cox regression), was evaluated. Results: PSM were observed in 39%; 11% had multiple PSM. Treatment failure was observed in 26% of all patients. Multivariably, the presence (hazard ratio 2.5) and number of PSM (hazard ratios...

... 1.03, 95% CI 1.00-1.06; p = 0.04) but not origin of diagnosis were independent predictors for treatment necessity. Four men developed biochemical recurrence (all from O-AS group [p = 0.05]). Conclusion: The origin of PCa diagnosis in men undergoing AS had no influence on disease progression...

... undergoing surgery develop biochemical recurrence, manifested as a rising prostate-specific antigen (PSA). Those patients are at higher risk of developing a local or distant recurrence. The diagnosis of a nodal recurrence is challenging. This report is about a 66-year-old male, who had a radical...

... ]. Statins Prostate cancer Radical prostatectomy Pathological characteristics Biochemical recurrence Functional outcome © 2013 S. Karger AG, Basel 2013 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages...

... setting of prostate cancer patients and could delay toxic systemic therapy up to 12 months. 9 06 2011 20 11 2011 7 3 2012 Lymph node dissection Biochemical recurrence PET-CT imaging Prostate cancer © 2012 S. Karger AG, Basel 2012 Copyright / Drug Dosage / Disclaimer...

...Kenji Kuroda; Akio Horiguchi; Takako Asano; Shinsuke Tasaki; Hidehiko Yoshii; Akinori Sato; Junichi Asakuma; Keiichi Ito; Kenji Seguchi; Makoto Sumitomo; Tomohiko Asano Introduction: Lymphatic invasion has been associated with biochemical recurrence (BCR), and many patients with postoperative...

.... All polymorphisms were detected by PCR-RFLP. Their prognosis on biochemical recurrence was assessed using Kaplan-Meier analysis and Cox regression model. Results:p53 codon 72 GG genotype was associated with increased biochemical recurrence compared with CG+CC genotypes and poorer PSA-free survival...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Radical prostatectomy Biochemical recurrence Biopsy Anastomosis Urologia Internationalis Original Paper Urol Int 2008;81:23 28 DOI: 10.1159/000137636 Received: August...

... Biochemical recurrence Prostate-specific antigen Ultrasensitive assay Linear models Urologia Internationalis Original Paper Urol Int 2007;79:356 360 DOI: 10.1159/000109723 Received: August 28, 2006 Accepted after revision: January 31, 2007 Inadequacy of Prostate-Specific Antigen Doubling Time Estimates...

...Hans-Peter Schmid; Franz U. Keuler; Jens E. Altwein Objective: To evaluate systematically the current endocrine treatment options for patients with biochemical recurrence after radical prostatectomy or radiation therapy for localized prostate cancer. Methods: Literature search of PubMed documented...

...Hideaki Miyake; Isao Hara; Toshifumi Kurahashi; Mototsugu Muramaki; Kazuki Yamanaka; Taka-aki Inoue; Masato Fujisawa Introduction: The objective of this study was to characterize clinicopathological features of patients with biochemical recurrence after radical prostatectomy who did not exhibit...

... and/or a biopsy Gleason score of 8–10. Biochemical recurrence was defined as a serum PSA level of ≧0.2 ng/ml. The data of these patients were retrospectively reviewed to clarify the relationships between treatment outcomes and various clinicopathological parameters. Results: The clinical stage was T2c in 13...